This site requires JavaScript to render the code.

Need to know how to enable JavaScript? Go here.

February 2019, Results from an international study confirm the robustness of the QIAsure Methylation Test
November 2018, QIAGEN launches Self-screens HPV-Risk Assay as the QIAscreen HPV PCR Test
September 2018, Self-screen successfully passed the transition to the ISO13485:2016 standard
July 2018, Focal trial shows significantly lower CIN3+ incidence for women primary screened for HPV compared to cytology
May 2018, United States Patent and Trademark Office grants patent of methylation markers PRDM14 and FAM19A4 to Self-screen B.V.
April 2018, QIAsure presented at the Polish Society of Colposcopy and Cervical Pathophysiology